RxDoctor Payments Data

Anselmo Fuentes-Aponte, MD

Family Medicine · Toa Baja, PRNPI 1053368985

Payments from drug & device makers

$756in general payments, 2019–2025

Across 38 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$280
  • PBG Puerto Rico LLC$170
  • Eli Lilly Export S.A. Puerto Rico Branch$109
  • Boehringer Ingelheim$59
  • Merck$56
  • Johnson & Johnson$46
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$756100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca15$280
PBG Puerto Rico LLC7$170
Eli Lilly Export S.A. Puerto Rico Branch5$109
Boehringer Ingelheim4$59
Merck3$56
Johnson & Johnson2$46
E.r. Squibb & Sons, L.L.C.1$22
Pfizer Pharmaceuticals LLC1$15

How this compares

$756 in reported general payments places this provider in the 75th percentile of 497 family medicine providers in Puerto Rico.

See all family medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$4,755
Medicare patients
17
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin48$54,248
FarxigaDapagliflozin Propanediol51$47,759
SynthroidLevothyroxine Sodium334$37,198
EliquisApixaban55$34,043
TrulicityDulaglutide25$24,669
JanuviaSitagliptin Phosphate19$18,398
XareltoRivaroxaban13$17,959
EntrestoSacubitril/Valsartan17$16,215
LinzessLinaclotide16$13,221
MyrbetriqMirabegron14$10,136
Janumet XrSitagliptin Phos/Metformin Hcl20$9,422
LantusInsulin Glargine,hum.Rec.Anlog81$9,354
LumiganBimatoprost23$8,638
TradjentaLinagliptin12$8,369
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate30$8,099

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$59$62,61760 claims
AstraZenecaFarxiga$280$47,75951 claims
MerckJanuvia, Janumet Xr$56$27,82039 claims
Johnson & JohnsonXarelto$46$17,95913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 497 family medicine providers in Puerto Rico.

Other family medicine in Toa Baja

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →